Shahin Gharakhanian MD, DPH, is a Physician-Executive with Expertise in Pharmaceutical Medicine, Leadership and Management, and an international track record. His passion is Patient-focused Programs for Novel Drug & Vaccine Development, Approval and Launch. He aims and strives to add value to Companies, notably by acting as Chief Medical Officer, via SABs (Scientific Advisory Boards) or ad hoc as Program Executive.

Dr Gharakhanian has conducted projects with 30 different global companies, 20 different brands and 4 NDA/MAA and/or new drug launches, including a blockbuster in 2011. These involved a variety of therapeutic areas and geographic regions [Asia, Canada, and EU, USA]. Leader-Builder with a track record of setting up three fully operational departments, one pharmaceutical company department, one CRO, one academic clinical unit and four LLCs.

Boston Paris Biotechnology Summit™ MISSION:

An exclusive, Trans-Atlantic bridge designed to foster innovative synergies between biotech and pharma companies, healthcare-focused cities and regional clusters and institutional, philanthropic and strategic investors. The Summit’s intent is to spark projects, their financing and strategic deals in order to solve unmet medical needs and thus improve patient lives globally.